29 results match your criteria: "Yale School of Medicine and Yale New Haven Health[Affiliation]"
J Grad Med Educ
April 2023
is Assistant Professor of Medicine and Pediatrics, Department of Medicine, Yale School of Medicine.
Background: Despite increasing prevalence of longitudinal clinician educator tracks (CETs) within graduate medical education (GME) programs, the outcomes of these curricula and how participation in these tracks affects early career development remains incompletely understood.
Objective: To describe the experience and outcomes of participating in a CET and its effects on recent internal medicine residency graduates' perceived educator skills and early career development.
Methods: We conducted a qualitative study between July 2019 and January 2020 using in-depth semi-structured interviews of recently graduated physicians from 3 internal medicine residencies at one academic institution who had participated in a CET, the Clinician Educator Distinction (CED).
BMJ Health Care Inform
November 2022
Department of Clinical Operatons, Imprivata UK, Uxbridge, UK.
Background: Surging volumes of patients with COVID-19 and the high infectiousness of SARS-CoV-2 challenged hospital infection control/safety, staffing, care delivery and operations as few crises have. Imperatives to ensure security of patient information, defend against cybersecurity threats and accurately identify/authenticate patients and staff were undiminished, which fostered creative use cases where hospitals leveraged identity access and management (IAM) technologies to improve infection control and minimise disruption of clinical and administrative workflows.
Methods: Working with a leading IAM solution provider, implementation personnel in the USA and UK identified all hospitals/health systems where an innovative use of IAM technology improved facility infection control and pandemic response management.
Arthritis Care Res (Hoboken)
March 2023
Brigham and Women's Hospital, Boston University School of Public Health, and Harvard Medical School, Boston, Massachusetts.
Objective: Class III obesity (body mass index [BMI] ≥40 kg/m ) is associated with worse knee pain and total knee replacement (TKR) outcomes. Because bariatric surgery yields sustainable weight loss for individuals with BMI ≥40 kg/m , our objective was to establish the value of Roux-en-Y gastric bypass (RYGB) and laparoscopic sleeve gastrectomy (LSG) in conjunction with usual care for knee osteoarthritis (OA) patients with BMI ≥40 kg/m .
Methods: We used the Osteoarthritis Policy model to assess long-term clinical benefits, costs, and cost-effectiveness of RYGB and LSG.
J Res Natl Inst Stand Technol
March 2022
Yale School of Medicine and Yale New Haven Health, New Haven, CT 06510, USA.
The development of an international, precompetitive, collaborative, ultraviolet (UV) research consortium is discussed as an opportunity to lay the groundwork for a new UV commercial industry and the supply chain to support this industry. History has demonstrated that consortia can offer promising approaches to solve many common, current industry challenges, such as the paucity of data regarding the doses of ultraviolet-C (UV-C, 200 nm to 280 nm) radiation necessary to achieve the desired reductions in healthcare pathogens and the ability of mobile disinfection devices to deliver adequate doses to the different types of surfaces in a whole-room environment. Standard methods for testing are only in the initial stages of development, making it difficult to choose a specific UV-C device for a healthcare application.
View Article and Find Full Text PDFJ Cardiol Cases
March 2022
Department of Medicine, Yale-New Haven Health Greenwich Hospital, Greenwich, CT, USA.
Mural endocarditis is a rare subclass of infective endocarditis (IE) associated with intra-cardiac tumors, prosthesis, valvular vegetation's, or structural abnormalities such as ventricular septal defects. Bacteria classified as HACEK ( species, , and ) are rare causes of IE found in only 1.3% to 10% of cases.
View Article and Find Full Text PDFOTA Int
December 2021
Center for Musculoskeletal Care, Yale School of Medicine and Yale New Haven Health.
Objectives: To determine the effect of a standardized tranexamic acid (TXA) protocol on red blood cell transfusions and adverse events in fragility hip fracture patients.
Design: Retrospective cohort study.
Setting: Academic Tertiary Care Center.
J Res Natl Inst Stand Technol
August 2021
National Institute of Standards and Technology, Gaithersburg, MD 20899, USA.
The National Institute of Standards and Technology (NIST) hosted an international workshop on ultraviolet-C (UV-C) disinfection technologies on January 14-15, 2020, in Gaithersburg, Maryland, in collaboration with the International Ultraviolet Association (IUVA). This successful public event, as evidenced by the participation of more than 150 attendees, with 65% from the ultraviolet technology industry, was part of an ongoing collaborative effort between NIST and the IUVA and its affiliates to examine the measurement and standards needs for pathogen abatement with UV-C in the healthcare whole-room environment. Prior to and since this event, stakeholders from industry, academia, government, and public health services have been collaboratively engaged with NIST to accelerate the development and use of accurate measurements and models for UV-C disinfection technologies and facilitate technology transfer.
View Article and Find Full Text PDFJ Res Natl Inst Stand Technol
August 2021
Yale School of Medicine and Yale New Haven Health, New Haven, CT 06510, USA.
Patient well-being must be the driving force for determining standards for disinfection systems based on ultraviolet-C (UV-C) radiation. Reductions of inoculated bacteria on carriers is the optimal method of validating a UV-C-emitting system. We make specific, evidence-based recommendations regarding room description, organism selection, carrier material, quantity, orientations, and locations.
View Article and Find Full Text PDFClin Orthop Relat Res
February 2021
M. I. O'Connor, Director, Center for Musculoskeletal Care, Yale School of Medicine and Yale New Haven Health, New Haven, CT, USA.
Clin J Am Soc Nephrol
December 2020
Arbor Research Collaborative for Health, Ann Arbor, Michigan.
Peritoneal dialysis (PD)-associated peritonitis is the leading cause of permanent transition to hemodialysis among patients receiving PD. Peritonitis is associated with higher mortality risk and added treatment costs and limits more widespread PD utilization. Optimizing the prevention of peritonitis in the United States will first require standardization of peritonitis definitions, key data elements, and outcomes in an effort to facilitate nationwide reporting.
View Article and Find Full Text PDFJ Heart Lung Transplant
September 2020
Center for Outcomes Research & Evaluation (CORE), Yale School of Medicine and Yale New Haven Health, New Haven, Connecticut; Section of Cardiovascular Medicine, Yale School of Medicine and Yale New Haven Health, New Haven, Connecticut. Electronic address:
Background: Tricuspid regurgitation (TR) is common in patients with end-stage heart failure receiving left ventricular assist devices (LVADs), but the benefit of concomitant tricuspid valve procedures (TVPs) remains uncertain. This study examined the impact of TVP at the time of LVAD implantation on clinical outcomes and quality of life (QOL) metrics.
Methods: We included adult patients in the Interagency Registry for Mechanical Circulatory Support database with various degrees of TR who received continuous-flow LVADs from 2008 to 2017.
JACC Heart Fail
July 2020
Division of Cardiac Surgery, Yale School of Medicine and Yale New Haven Health, New Haven, Connecticut; Center for Outcomes Research & Evaluation, Yale School of Medicine and Yale New Haven Health, New Haven, Connecticut. Electronic address:
Background: Psychiatric comorbidities play a key role in patient selection for left ventricular assist devices (LVADs), but their impact on clinical outcomes is unknown.
Objectives: The goal of this study was to examine the clinical impact of psychiatric illness on outcomes in patients receiving LVADs for end-stage heart failure (HF).
Methods: The study identified adults in the Interagency Registry for Mechanically Assisted Circulatory Support with psychiatric comorbidities (history of alcohol abuse, drug use, narcotic dependence, depression, and other major psychiatric diagnoses) receiving continuous-flow LVADs from 2008 to 2017.
J Thorac Cardiovasc Surg
August 2020
Division of Cardiac Surgery, Yale School of Medicine and Yale New Haven Health, New Haven, Conn.
J Am Coll Radiol
December 2020
Yale School of Medicine, New Haven, Connecticut; Yale New Haven Health, Department of Medicine, Section of Digestive Diseases, New Haven, Connecticut.
Background And Aims: Hepatocellular carcinoma (HCC) is a complex and unique cancer. At many tertiary care institutions, optimal treatment is planned at a multidisciplinary liver tumor board (MDLTB). This study examined the impact of referral on MDLTB outcomes for patients with HCC.
View Article and Find Full Text PDFClin Orthop Relat Res
June 2020
M. I. O'Connor, Director, Center for Musculoskeletal Care, Yale School of Medicine and Yale New Haven Health, New Haven, CT, USA.
Diabetes Care
May 2020
Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations, Houston, TX
Clin Orthop Relat Res
March 2020
M. I. O'Connor, Director, Center for Musculoskeletal Care, Yale School of Medicine and Yale-New Haven Health, New Haven, CT, USA.
HSS J
October 2019
Center for Musculoskeletal Care, Department of Orthopaedics and Rehabilitation, Yale School of Medicine and Yale New Haven Health, New Haven, CT USA.
Clin Orthop Relat Res
November 2019
M. I. O'Connor, Director, Center for Musculoskeletal Care, Yale School of Medicine and Yale-New Haven Health, New Haven, CT, USA.
Clin J Am Soc Nephrol
January 2020
Department of Medicine, University of Arizona, Tucson, Arizona.
Am J Kidney Dis
November 2019
New York Medical College, Westchester Medical Center, Valhalla, NY.
Clin Orthop Relat Res
August 2019
M. I. O'Connor, Director, Center for Musculoskeletal Care, Yale School of Medicine and Yale-New Haven Health, New Haven, CT, USA.
Clin Orthop Relat Res
May 2019
M. I. O'Connor, Director, Center for Musculoskeletal Care, Yale School of Medicine and Yale-New Haven Health, New Haven, CT, USA.
Kidney Int
April 2019
Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA; Renal, Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
The safety and efficacy of spironolactone is uncertain in end-stage renal disease. We randomized 129 maintenance hemodialysis patients to placebo (n=51) or spironolactone 12.5 mg (n=27), 25 mg (n=26), or 50 mg (n=25) daily for 36 weeks in a double-blind, placebo-controlled, multiple dosage trial to assess safety, tolerability and feasibility and to explore cardiovascular efficacy.
View Article and Find Full Text PDFHemodial Int
October 2017
Division of Nephrology, Department of Medicine, Stanford University School of Medicine, Palo Alto, California, USA.
Introduction: End-stage renal disease (ESRD) is associated with perturbations in thyroid hormone concentrations and an increased prevalence of hypothyroidism. Few studies have examined the effects of hemodialysis dose or frequency on endogenous thyroid function.
Methods: Within the Frequent Hemodialysis Network (FHN) trials, we examined the prevalence of hypothyroidism in patients with ESRD.